Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
INNV · against 454 other Healthcare companies listed in US-listed
Ranked #224 of 455 · scores higher than 50% of peers
Bars: peers in each 10-point band of the growth score45 peers with a growth score of 60–69, including INNV · Click a bar to see the companies
Mainly thanks to its revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.
| Metric | INNV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | 15.9% | 11.0% | 59% | 33% | |
| Earnings per share growthHigher is better · 171 reported | Not reported | 21.2% | — | — | 33% |
| 3-year revenue growthHigher is better · 433 reported | 12.9% | 11.0% | 55% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 460M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 441M USD | 99 | 81 | |
| 2 | 9.5B USD | 99 | 31 | |
| 2 | 87M USD | 99 | 27 | |
| 219 | 5.4B USD | 66 | 50 | |
| 219 | 1.7B USD |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 33 |
| 224 | 1.3B USD | 65 | 42 |
| 224 | 3.0B USD | 65 | 44 |
| 224 | 1.3B USD | 65 | 49 |
| 224 | 9.5B USD | 65 | 29 |
| 224 | 2.1B USD | 65 | 29 |
| 229 | 477M USD | 64 | 24 |
| 229 | 293.1B USD | 64 | 63 |